These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28439054)

  • 21. Re: Estrogen-progestin contraceptive use during adolescence prevents bone mass acquisition: a 4-year follow-up study.
    Schilling LH
    Contraception; 2009 Mar; 79(3):241; author reply 241-2. PubMed ID: 19185682
    [No Abstract]   [Full Text] [Related]  

  • 22. [Calcium and bone metabolism across women's life stages. Bone metabolism of women in primary amenorrhea.].
    Higuchi T
    Clin Calcium; 2017; 27(5):653-660. PubMed ID: 28439053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA; Oza BP; Colomer R; Lupu R
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral contraceptive use and impact of cumulative intake of estrogen and progestin on risk of ovarian cancer.
    Faber MT; Jensen A; Frederiksen K; Glud E; Høgdall E; Høgdall C; Blaakaer J; Kjaer SK
    Cancer Causes Control; 2013 Dec; 24(12):2197-206. PubMed ID: 24077761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacodynamics of combined estrogen-progestin oral contraceptives: 1. Effects on metabolism.
    Bastianelli C; Farris M; Rosato E; Brosens I; Benagiano G
    Expert Rev Clin Pharmacol; 2017 Mar; 10(3):315-326. PubMed ID: 27977304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral contraceptive use in young women is associated with lower bone mineral density than that of controls.
    Almstedt Shoepe H; Snow CM
    Osteoporos Int; 2005 Dec; 16(12):1538-44. PubMed ID: 15902418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rationale for new oral contraceptive dosing.
    Williams JK
    Int J Fertil Womens Med; 2004; 49(1):30-5. PubMed ID: 15038507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Estrogens, progestins and blood lipids].
    Tikkanen MJ
    Duodecim; 1984; 100(22):1500-3. PubMed ID: 6518995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Serious adverse effect of combined oral contraceptive pills among teenagers].
    Nylander MC; Clausen HV
    Ugeskr Laeger; 2014 Jun; 176(26):V05130336. PubMed ID: 25294576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The formulation of oral contraceptives: does the amount of estrogen make any clinical difference?
    Speroff L
    Johns Hopkins Med J; 1982 May; 150(5):170-6. PubMed ID: 7043035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alterations of maternal estrogen levels during gestation affect the skeleton of female offspring.
    Migliaccio S; Newbold RR; Bullock BC; Jefferson WJ; Sutton FG; McLachlan JA; Korach KS
    Endocrinology; 1996 May; 137(5):2118-25. PubMed ID: 8612556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oestrogen-progestogen oral contraceptives and urinary calcium excretion.
    Goulding A; McChesney R
    Clin Endocrinol (Oxf); 1977 Jun; 6(6):449-54. PubMed ID: 884877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of progestins on estrogen-induced increase in C-reactive protein in postmenopausal women.
    Rossi R; Bursi F; Veronesi B; Cagnacci A; Modena MG
    Maturitas; 2004 Dec; 49(4):315-20. PubMed ID: 15531127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bones are breaking without estrogen].
    Komulainen M; Tuppurainen M; Kröger H
    Duodecim; 2003; 119(22):2183-9. PubMed ID: 14702807
    [No Abstract]   [Full Text] [Related]  

  • 35. Overview on the effects of progestins on bone.
    Thijssen JH
    Maturitas; 2003 Dec; 46 Suppl 1():S77-87. PubMed ID: 14670649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of oral contraceptives on peripheral blood flow in untrained women at rest and during exercise.
    Cottingham MA; Smith JD; Criswell DS
    J Sports Med Phys Fitness; 2001 Mar; 41(1):83-8. PubMed ID: 11317153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hormonal contraception using estroprogestins].
    Grio R; Piacentino R; Cellura A; Caccuri D; Zaccheo F; Baccarini G; Marchino GL; Borgarino S; Fuda G
    Minerva Ginecol; 1990 Mar; 42(3):49-53. PubMed ID: 2187166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral contraceptives in 1984.
    Chapler EK
    Iowa Med; 1984 Oct; 74(10):439-40, 442. PubMed ID: 6490338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-dose oral contraceptives: progestin potency, androgenicity, and atherogenic potential.
    Ellis J
    Clin Ther; 1986; 8(6):607-18. PubMed ID: 3539347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Calcium and bone metabolism across women's life stages. Bone quality and treatment of osteoporosis by SERM.].
    Saito M; Marumo K
    Clin Calcium; 2017; 27(5):723-732. PubMed ID: 28439061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.